Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp
The increase of diseases caused by Candida spp., and the treatment failures, has underscored the need for testing the susceptibilities to antifungal agents. The commercial panel ATB® Fungus 2 was compared with the reference testing method of the European Subcommittee on Antifungal Susceptibility Tes...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Publicaciones UIS
2014-04-01
|
Series: | Salud UIS |
Subjects: | |
Online Access: | http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-08072014000100002&lng=en&tlng=en |
_version_ | 1797719167485345792 |
---|---|
author | Jehidys Estella Montiel Ramos Andrea Corrales Bernal María Paulina Vélez Bravo Armando Baena Zapata Ana Cecilia Mesa Arango |
author_facet | Jehidys Estella Montiel Ramos Andrea Corrales Bernal María Paulina Vélez Bravo Armando Baena Zapata Ana Cecilia Mesa Arango |
author_sort | Jehidys Estella Montiel Ramos |
collection | DOAJ |
description | The increase of diseases caused by Candida spp., and the treatment failures, has underscored the need for testing the susceptibilities to antifungal agents. The commercial panel ATB® Fungus 2 was compared with the reference testing method of the European Subcommittee on Antifungal Susceptibility Testing of the Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) for the evaluation of the susceptibility of isolates of Candida spp. to three agents. The percentage of agreement was calculated based on the minimum inhibitory concentrations. There was a high correlation for AMB (100% қ = 1.0 Bhapkar coefficient p = 1.0); while it was lower with azoles (85%, қ = 0.41, p = Bhapkar coefficient 0.02 and 83.0%, қ = 0.15, Bhapkar coefficient p = 0.0006, respectively). The ATB® Fungus 2 and AFST-EUCAST are fully comparable methods for testing the susceptibility to AMB and to lesser extend comparable for ITR and FCA |
first_indexed | 2024-03-12T09:01:07Z |
format | Article |
id | doaj.art-973f3b50d40e4a2591fbbbfcf6bff760 |
institution | Directory Open Access Journal |
issn | 0121-0807 |
language | English |
last_indexed | 2024-03-12T09:01:07Z |
publishDate | 2014-04-01 |
publisher | Publicaciones UIS |
record_format | Article |
series | Salud UIS |
spelling | doaj.art-973f3b50d40e4a2591fbbbfcf6bff7602023-09-02T15:40:54ZengPublicaciones UISSalud UIS0121-08072014-04-01461714S0121-08072014000100002Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida sppJehidys Estella Montiel Ramos0Andrea Corrales Bernal1María Paulina Vélez Bravo2Armando Baena Zapata3Ana Cecilia Mesa Arango4Universidad de AntioquiaUniversidad de AntioquiaUniversidad de AntioquiaUniversidad de AntioquiaUniversidad de AntioquiaThe increase of diseases caused by Candida spp., and the treatment failures, has underscored the need for testing the susceptibilities to antifungal agents. The commercial panel ATB® Fungus 2 was compared with the reference testing method of the European Subcommittee on Antifungal Susceptibility Testing of the Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) for the evaluation of the susceptibility of isolates of Candida spp. to three agents. The percentage of agreement was calculated based on the minimum inhibitory concentrations. There was a high correlation for AMB (100% қ = 1.0 Bhapkar coefficient p = 1.0); while it was lower with azoles (85%, қ = 0.41, p = Bhapkar coefficient 0.02 and 83.0%, қ = 0.15, Bhapkar coefficient p = 0.0006, respectively). The ATB® Fungus 2 and AFST-EUCAST are fully comparable methods for testing the susceptibility to AMB and to lesser extend comparable for ITR and FCAhttp://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-08072014000100002&lng=en&tlng=enantifungal susceptibilityCandida sppATB® Fungus 2AFST-EUCASTsusceptibilidad antifúngicaCandida sppATB® Fungus 2AFST-EUCAST |
spellingShingle | Jehidys Estella Montiel Ramos Andrea Corrales Bernal María Paulina Vélez Bravo Armando Baena Zapata Ana Cecilia Mesa Arango Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp Salud UIS antifungal susceptibility Candida spp ATB® Fungus 2 AFST-EUCAST susceptibilidad antifúngica Candida spp ATB® Fungus 2 AFST-EUCAST |
title | Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp |
title_full | Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp |
title_fullStr | Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp |
title_full_unstemmed | Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp |
title_short | Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp |
title_sort | comparison of the atb r fungus 2 with the afst eucast for in vitro susceptibility testing of candida spp |
topic | antifungal susceptibility Candida spp ATB® Fungus 2 AFST-EUCAST susceptibilidad antifúngica Candida spp ATB® Fungus 2 AFST-EUCAST |
url | http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-08072014000100002&lng=en&tlng=en |
work_keys_str_mv | AT jehidysestellamontielramos comparisonoftheatbfungus2withtheafsteucastforinvitrosusceptibilitytestingofcandidaspp AT andreacorralesbernal comparisonoftheatbfungus2withtheafsteucastforinvitrosusceptibilitytestingofcandidaspp AT mariapaulinavelezbravo comparisonoftheatbfungus2withtheafsteucastforinvitrosusceptibilitytestingofcandidaspp AT armandobaenazapata comparisonoftheatbfungus2withtheafsteucastforinvitrosusceptibilitytestingofcandidaspp AT anaceciliamesaarango comparisonoftheatbfungus2withtheafsteucastforinvitrosusceptibilitytestingofcandidaspp |